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Introduction
The microvasculature is actively involved in metabolism and immune cell trafficking. While the supply with oxygen and nutrients as well as the attraction of leukocytes is accomplished by blood vessels, the removal of extracellular fluid from the tissues and the guidance of immune cells to lymph nodes are carried out by lymphatic vessels. At the molecular level, these different functional capabilities are likely encoded by the transcriptional repertoires of blood vessel endothelial cells (BECs) and lymphatic ECs (LECs). Recently, the discovery of the LEC-specific marker proteins podoplanin (PDPN) and LYVE-1 allowed to isolate and propagate BECs and LECs in vitro 1, 2 . Accordingly, several techniques including genomewide expression profiling coupled to bioinformatic approaches have been used to identify the spectrum of genes that are expressed in cultured LECs and BECs [3] [4] [5] [6] . However, probably due to technical limitations, genome-wide analyses were not performed on freshly isolated ECs.
Thus, it is possible that ECs, in their tissue-resident state, have a transcriptional and, thus, functional repertoire that differs from that of cultured ECs. In fact, the specialized ECs of high endothelial venules rapidly lose EC subset-defining antigen expression and morphology when these cells were placed in culture 7 . This supports that active signal exchange between ECs and the local tissue environment can also be of critical importance for the maintenance of 
Cell isolation
Skin was obtained on informed consent from healthy adults undergoing elective surgery (breast reduction and abdominoplasty). Dermal and epidermal sheets were prepared from 0.8-mm split-thickness skin by an incubation with dispase I (3 U/ml; Roche, Basel, Switzerland)
for 60 min at 37°C. Microvascular ECs were released from dermal sheets by gentle scraping.
Cells were pelleted, resuspended in ice-cold EC growth medium MV (PromoCell, Heidelberg, Germany), and subjected to immunostaining and FACS (FACSAria; BD). Dermal cell suspensions containing fibroblasts, mast cells, and dermal dendritic cells (DDCs) were prepared by dissociating collagenase IV (0.5 U/ml, 90 min at 37°C; Worthington, Lakewood, NJ)-treated, minced dermal tissue using a cell dissociation sieve (Sigma-Aldrich, St. Louis, MO). Cells were pelleted, resuspended in ice-cold RPMI1640/10% FCS, immunostained, and subjected to FACS. Single cells were released from epidermal sheets using 0.25% trypsin/EDTA (30 min at 37°C; Invitrogen, San Diego, CA). Cells were sedimented over 
Culture of microvascular ECs
EC-enriched dermal cells were seeded on fibronectin (Invitrogen)-coated dishes and cultured in supplemented EC growth medium MV without hydrocortisone. After having reached confluence, ECs were harvested using a brief incubation with dispase I, and contaminating cells were removed by anti-CD31-based MACS. After this purification step (passage 1) or after the indicated passages, ECs were subjected to immunostaining and FACS-based separation into BECs and LECs.
FACS and RNA isolation
After labeling with appropriate fluorochrome-labeled mAbs, dermal cells were sorted into 
RNA amplification and Affymetrix GeneChip hybridization
Total RNA was subjected to 2 rounds of linear amplification as described 10, 11 . Biotin-labeled ribonucleotides were incorporated using the ENZO Bio-Array High-Yield RNA Transcript
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Ten micrograms fragmented cRNA were hybridized to Human Genome U133 Plus 2.0 Array (Affymetrix).
Data normalization and bioinformatic analyses
Microarray data was normalized using the Robust Multi-Array Analysis as implemented in Bioconductor 12, 13 . All analyses were performed with log 2 -transformed data. The volcano plot analysis was used to provide a summary of test statistics for differential expression of genes.
BEC and LEC samples were compared to the remaining non-EC cell types either together or alone. Hypothesis tests were performed using a modified t-statistics with an empirical Bayes approach as implemented in Bioconductor LIMMA package 14 . Unsupervised hierarchical clustering was performed using the Unweighted Pair Group Method with Arithmetic Mean (UPGMA) method after sorting all probe set results by their coefficient of variation using the Pearson correlation coefficient distance measure. For unsupervised network analyses, the Ingenuity Pathway Analysis System (Ingenuity® Systems, Redwood City, CA) was used.
Quantitative PCR
Quantitative (q)PCR was performed as described previously 11 
Immunofluorescence microscopy
Cryostat sections from fresh normal human skin (n=3) or cutaneous melanoma metastases (n=5) were mounted on slides, and fixed for 10 min in acetone at -20°C. Sections were incubated for 30 min in 1% BSA/PBS before simultaneous exposure to goat anti-CD144-biotin, rabbit anti-podoplanin, and the indicated mouse mAbs. Binding of primary Abs was revealed by an incubation with Alexa 633-conjugated streptavidin, Alexa 488-conjugated goat anti-rabbit IgG, and TRITC-labeled goat anti-mouse IgG. Samples were analyzed by confocal laser scanning microscopy (LSM 520; Zeiss, Jena, Germany).
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Results

Genome-wide expression profiling of freshly isolated human skin cell types
To analyze freshly isolated EC subsets, we established optimized protocols for tissue (skin) dissociation, cell purification, and extraction as well as linear amplification of total RNAs for genome-wide expression profiling. Accordingly, dermal cells were dissociated from human split-thickness skin of healthy donors and ECs were identified by their homogeneous expression of VE-cadherin ( Figure 1A . Thus, our strategy provided high quality datasets containing the genome-wide transcriptomes of important human skin cell types in their fresh, non-cultured state.
The set of genes defining EC identity in vivo
To identify the genes that are expressed in ECs in vivo but not in other skin cell types (referred to as pan-EC genes), we displayed the pool of genes that are expressed by both BECs and LECs against the pooled transcriptomes of all non-EC cell types. The comparison of primary ECs and pooled primary control cells revealed the average difference in expression and the corresponding p-value for each expressed gene ( Figure 2A ). Selective pan-EC genes were defined by an expression in ECs that is >10 fold higher than in control cell types and by a p-value of <10 -4 . Using this criterion, 188 genes were found to define EC identity. 28 pan-EC genes remain when the required expression difference is raised to >20 and the p-value threshold is lowered to <10 -7 (genes listed in Supplemental Table S1 ). Confirming the validity and quality of the results, several identified genes code for proteins with established vascular
For personal use only. on October 28, 2017. by guest www.bloodjournal.org From functions (VE-cadherin, von Willebrand factor, VEGFR2/KDR, angiopoietin receptor 2/TIE-2). Our analysis also revealed additional human pan-EC-defining genes like APOLD1, previously identified as a vessel-specific transcript in rats 17 , as well as ECSM2 and
Hs.638786, coding for proteins of still unknown functions. Interestingly, the homeobox gene HOXD10 was expressed in both LECs and BECs abundantly but not in other skin cell types.
Moreover, several yet poorly investigated GTPase-related molecules (Rho GAP29, IMAP6, and IMAP8), G protein-coupled receptors (EDG1), tyrosine phosphatases (PTPRB) and mucin-type receptors (endomucin, podocalyxin-like/PODXL) define EC identity in vivo.
The sets of genes defining EC subset identity in vivo
As shown in Figure 2B , 82 genes were found that define LEC identity in vivo (>10-fold higher expression in LECs than in control cells, p<0.001). 21 genes remain when we superimposed the further criterion of >10 fold higher expression in LECs than in BECs and a corresponding p-value of <10 -6 (bold in Supplemental Table S2 ). The identified set of genes validates LEC-specific expression of CC chemokine ligand (CCL)21 and PROX-1 in vivo.
Three other previously suggested LEC-specific molecules, i.e., PDPN, LYVE-1, and FOXC2
were clearly enriched in LECs in vivo, but are also dimly expressed in other skin cells (Supplemental Table S2 ). Three novel LEC-specific genes/gene regions were identified Few genes with BEC-specific expression patterns have been described so far. Our analysis reveals that 89 genes define BEC identity in vivo using the criterion of >10 fold
For personal use only. on October 28, 2017. by guest www.bloodjournal.org From higher expression in BECs than in the pooled reference cell group and a p-value of <0.0001 ( Figure 2C ). 23 genes remain when the further criterion of >10 fold higher expression in BECs than in LECs and a corresponding p-value of <10 -6 is superimposed (bold in Supplemental Table S3 ). Several of these most explicitly BEC-specific genes are of importance for blood vessel integrity/cell adhesion (JAM2, melanoma cell adhesion molecule/MCAM/CD146). Newly identified BEC-specific molecules are involved in substrate transport across vessel walls (aquaporin 1, glutamate transporter SLC1A1), or in nitric oxide (nitric oxide synthase trafficker/NOSTRIN) and neurotrophic signaling (neurokinin/substance P receptor/TACR1). While the homeobox genes PROX-1 and FOXC2
are of established importance for LEC differentiation 18, 19 , no master regulator of BEC-specific gene transcription has been identified so far. We find that the mesenchyme homeobox gene MEOX-1 is the superior BEC-defining gene in vivo. Also interesting was that BECs, but not other skin cells, even in their non-activated in vivo state express transcripts coding for molecules with importance for leukocyte adhesion (E-and P-selectin) and migration (CCL23, Duffy antigen).
Expression of 10 selected genes that were found overexpressed in BECs in the microarray studies was also analyzed in the 3 prospective pairs of BECs and LECs ( Figure   3B ). By qRT-PCR, 10 of 10 genes were found drastically overexpressed in BECs as compared to LECs with a range of mean expression difference from 17.8 to 3100. As a control, the pan-EC genes CD144 and CD31 were expressed in BECs and LECs almost equally (mean expression difference 1.6 and 1.7, respectively; Figure 3 ). Thus, data obtained by qRT-PCR also verify the identification of BEC-specific gene expression by expression profiling.
MHC class II expression is a hallmark feature of the in vivo differentiation program of BECs
In an unbiased approach, lists of genes that are overexpressed in BEC as compared to LECs and vice versa were subjected to bioinformatic data mining to identify functional programs.
With BECs, transcripts coding for the full complement of MHC class II (HLA-DR, HLA-DP, HLA-DQ) and MHC class II-related molecules (HLA-DM, invariant chain/CD74) formed the prominent part of the interaction plot (Supplemental Figure S1 ). Within the pan-EC gene list, networks were identified that are important for vessel wall formation (TIE-1, TIE-2), the formation of cell junctions (CD31, VE-cadherin), angiogenesis (VEGFR2/KDR) and the establishment of the basement membrane (COLIV).
To corroborate the surprising observation of constitutive MHC class II expression by normal BECs at the protein level, we performed confocal microscopy on snap-frozen normal human skin and flow cytometry on freshly isolated BECs and LECs. Substantial MHC class II protein expression was detected in the ECs lining blood vessels of both the superficial and deep vascular plexus of the skin ( Figure 4A ). Lymphatic vessels in situ were devoid of anti-MHC class II immunoreactivity which is in agreement with the results of our transcriptional analysis. The striking difference in MHC class II protein expression between BECs and LECs was also evident in flow cytometry analysis of freshly isolated EC subsets ( Figure 4C ).
MHC class II expression is part of a strictly environmentally regulated BEC differentiation program
While few older reports noted anti-MHC class II immunoreactivity on some microvessels in normal human skin 20, 21 , resting ECs in vitro lack MHC class II expression unless stimulated with inflammatory cytokines [22] [23] [24] . Thus, MHC class II expression may be part of a distinctive BEC differentiation program that is regulated by the tissue environment but lost under in vitro conditions. To identify the pool of genes that are under stringent control of the physiologic tissue environment, we comparatively analyzed gene expression by freshly isolated and in vitro propagated EC subsets.
Unsupervised hierarchical clustering of genes expressed by primary and cultured LECs and BECs clearly separated primary ECs from their cultured counterparts ( Figure 5A ).
Intriguingly, the BEC-and the LEC-specific in vivo gene expression programs were largely lost upon propagation of the EC subsets in vitro ( Figure 5A ). The BEC-and LEC-defining gene expression profiles were lost till the earliest possible harvest of the in vitro propagated cells (passage 1, Figure 5A ). Only a subset of downregulated BEC-specific genes was expressed at detectable levels till passage 1 (mesenchyme homeobox 1, MEOX1; E-selectin;
ELOVL family member 7, SPARC-like-1) or passage 2 (COL15A1; Figure 5A ). In fact, >65% of the 40 most selectively in vivo expressed BEC genes were silenced in vitro ( Figure   5B ). Similarly, >50% of the 40 transcripts that best define LECs in vivo were downregulated in vitro. Comparatively less pronounced was the loss of pan-EC-defining gene expression (only 20% of the 40 most selective pan-EC transcripts are lost in vitro) with a strictly coordinated loss of expression in BECs and LECs ( Figure 5C) . Thus, our analysis shows a loss of EC subset identity and a striking assimilation of LEC and BEC transcriptomes in vitro.
Expression of MHC class II and MHC class II-related proteins was also completely lost upon EC culture in vitro ( Figures 4C and 5A ), contrasting the maintained expression of Figure 6B ). Thus, the relative level of endogenous self peptide display in MHC class II is higher in BECs than in DCs ( Figure 6C ). This indicates that BECs in vivo are able and, perhaps even, specialized to present self antigens efficiently.
For
ECs of tumor blood vessels, as normal BECs, can express peptide:MHC II complexes along with T cell activation-inhibiting members of the B7 family of costimulatory molecules
To see whether constitutive MHC class II presentation by BECs is of relevance in human cancer, we also analyzed the transcriptomes of tumor-derived BECs (TuECs) for the expression of MHC class II and costimulatory molecules. TuECs were purified from melanoma skin metastases and RNA was subjected to expression profiling. As shown in Figure 7C , TuECs and normal BECs expressed comparable levels of transcripts encoding MHC class II, HLA-DM, and invariant chain. At the protein level, TuECs expressed peptide:MHC class II complexes at levels comparable to VE-cadherin neg melanomainfiltrating macrophages ( Figure 7A ). The functionality of MHC class II processing and presentation in TuECs is further supported by the detection of transcripts encoding lysosomal proteases that are essential for antigen and Ii processing (cathepsins B, H, L and S) 25 at levels comparable to those in normal ECs. As shown in Figure 7D , normal BECs and TuECs, unlike DDCs, did not express transcripts encoding the stimulatory B7 family members B7.1 and
B7.2. In contrast, BECs and TuECs expressed transcripts for the T cell function-inhibitory/-
modulatory B7 molecules B7-H1, B7-H2, B7-H3, and B7-H4. Among those, the negative costimulatory molecule B7-H3 was most prominently expressed in TuECs. In aggregate, these data show that MHC class II biosynthesis, processing, and peptide display are part of a strictly environmentally regulated BEC program that is operative in normal as well as in neoplastic tissues.
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Discussion
In this study, we established the transcriptomes of freshly ex vivo isolated human cutaneous BECs and LECs. This became possible by the combined use of high-capacity multiparametric cell sorting and efficient linear RNA amplification for reliable and reproducible genome-wide expression profiling. Several other skin cell types were analyzed in parallel. This allowed the establishment of the "private" in vivo transcriptomes of BECs and LECs that do not overlap with transcriptomes of other skin cells. The obtained "in vivo" BEC and LEC transcriptomes revealed striking differences to transcriptomes that were previously obtained using cultured EC subsets obtained after 4 or 5 passages in vitro 5, 6 . This difference is explained by our In fact, we find that MEOX-1 expression is the best defining criterion of BEC differentiation in normal human skin. While a possible functional role of MEOX-1 in BECs still has to be established, its structural relative MEOX-2, which is expressed in both BECs and LECs (Supplemental Figure S2) , is a positive regulator of angiogenesis in vivo 28 . Thus, it is tempting to speculate that a concerted action of the two MEOX gene products is critical for BEC differentiation and function.
The homeobox gene HOXD10 was identified as an EC-defining gene in our study. In contrast to MEOX-1, we find HOXD10 to be stably expressed in culture. Functionally, HOXD10 expression is essential to maintain a nonangiogenic state in the endothelium 29 . This confirms that the ECs investigated, both ex vivo and in vitro, were in a bona fide resting, nonproliferative state. It was interesting to note that HOXD10 was among the genes the expression of which is most prominently downregulated in tumor ECs as compared to normal BECs (data not shown). Thus, it appears that in vivo HOXD10 can be the critical repressor of both angiogenesis and lymphangiogenesis. This together with our observation that BECs in normal human skin constitutively express B7 family members that are essential for the downregulation of T cell responses 30, 31 suggests that in vivo BECs negatively regulate CD4 + T cell reactivity to self proteins. The physical interaction of T cells and microvascular BECs in vivo may be promoted under slow flow conditions by the observed low level constitutive expression of E-and P-selectins, chemokines and ICAM-1, all features that we found to be strictly environment-regulated and lost upon EC culture ( Figure 4C , Supplemental Table S3 ) 32 . BECs in metastatic melanoma, to a similar extent as in normal skin, were found to express peptide:MHC class II complexes and display negative costimulatory molecules for T cell activation. This indicates that BECs could also contribute to T cell tolerance to tumor antigens. Due to the demonstrated rapid dedifferentiation of BECs in vitro, the resolution of the biologic impact of MHC class II on ECs for T cell activation clearly requires novel in vivo models that will allow for controlled expression of defined MHC class II complexes on BECs in their natural tissue surrounding.
In summary, the "in vivo" transcriptomes of BECs and LECs reveal novel EC subtype-restricted functionalities that are determined by the environment in which these cells reside. The further understanding of the environment-derived signals regulating these functions will be instrumental for the full understanding of lymphatic and blood vessel physiology and the ability to manipulate these cells in therapeutic settings.
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